Taiyen Biotech CoTPE:1737 83 PB Ratio is 0.94 as of Jul. 11, 2026, which is 8% below its 10-year median of 1.02. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.08 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,894 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 65.36% on this metric.
Taiyen Biotech Co Ltd stock PB Ratio (=0.94) is close to 10-year low of 0.9.
The historical rank and industry rank for Taiyen Biotech Co's PB Ratio or its related term are showing as below:
TPE:1737'
s PB Ratio Range Over the Past 10 Years
Min: 0.9 Med: 1.02 Max: 1.18
Current: 0.94
During the past 13 years, Taiyen Biotech Co's highest PB Ratio was 1.18. The lowest was 0.90. And the median was 1.02.
TPE:1737's PB Ratio is ranked better than 65.36% of 1894
companies
in the Consumer Packaged Goods industry
Industry Median: 1.36
vs TPE:1737: 0.94
During the past 12 months, Taiyen Biotech Co's average Book Value Per Share Growth Rate was 2.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 1.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Taiyen Biotech Co was 2.00% per year. The lowest was -4.50% per year. And the median was 1.15% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Taiyen Biotech Co PB Ratio Related Terms
Taiyen Biotech Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Taiyen Biotech Co (TPE:1737) has a PB Ratio of 0.94 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Taiyen Biotech Co and its competitors. This is near median its historical median of 1.02. Over the past decade, Taiyen Biotech Co's PB Ratio has ranged from 0.90 to 1.18. According to the industry distribution chart, Taiyen Biotech Co ranks #656 out of 1894 companies in the Consumer Packaged Goods industry, placing it in the top 34.6%.
Is Taiyen Biotech Co's PB Ratio too high?
Taiyen Biotech Co's current PB Ratio of 0.94 is near median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 1.18. The Consumer Packaged Goods industry median PB Ratio is 1.36. Taiyen Biotech Co's value of 0.94 is 30.9% below this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #656 out of 1894 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's PB Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #656 out of 1894 companies for PB Ratio. This puts Taiyen Biotech Co in the upper half of its industry. The industry median PB Ratio is 1.36. Taiyen Biotech Co's value of 0.94 is 30.9% below this benchmark. Historically, Taiyen Biotech Co's own PB Ratio has ranged from 0.90 to 1.18 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 1.36, Taiyen Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.36, based on 1,894 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current PB Ratio of 0.94 is 30.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current PB Ratio is 0.94, which is near median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.08, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current PB Ratio is 0.94, which is near median its 10-year median of 1.02 and 30.9% below the Consumer Packaged Goods industry median of 1.36. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current PB Ratio is 0.94 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.08.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
PB Ratio: 0.94 (near median its 10-year median of 1.02)
GF Value™: NT$32.08 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 30.9% below the Consumer Packaged Goods median (#656 of 1894)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
